Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Benralizumab
Study Title: A study to learn about the safety of benralizumab in healthy
Chinese participants in China
Thank you!
Thank you to the participants who took part in the clinical study for the study drug
benralizumab. AstraZeneca AB sponsored this study and thinks it is important to
share the results. An independent non-profit organization called CISCRP helped
prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study started in April 2019 and ended in August 2019. It included
36 participants in China.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1